Her talks ends with summary of issues:
🔹Different triggers ID different patients
🔹The outcomes are variable
🔹Undefined overlap between palliative care and ICU care
(That last one rings a lot of bells for me) 🔔
And so to move forward we need to:
🔹Define a what *we* say PC is
🔹Train clinicians in ICU 🎉
🔹Develop ICU specific triggers to identify patients
❓Audience member asks should we call it something more acceptable…supportive care?
Hartog says no - call it what it is
❓Another Q asks how to handle bad reaction, but i don’t grasp a clear answer
(My answer = patient empathetic communications, but be true to what it is)
We’re hearing from @JosLatour1 now whose talk is about team work. He talks about the NHS definition of palliative care
And specifies it is broader than EOL care
Who are ‘we’ in the team?
—> includes family (chosen or otherwise)
He says Pts and family are at the forefront and referenced a recent patient speaker at @BACCNUK condense who said ‘my relatives always felt awkward and in the way’ (sorry 😞)
He ask should we involve them palliative care team?
He says he is both a ‘Never’
And a ‘Never say Never’
They should be involved before ICU where the condition is long term…
But with acute life limiting conditions admitted to ICU…. No never (but maybe not never never)
He says we should actively cultivate that culture of inter professional team work
This paper is linked and he talks of having strategies to create the necessary climate
(I get this, the right culture change doesn’t happen without effort)
A pathway to collaborative working with relatives…
(Not sure I’ll use the wheel but like an example about enhancing family confidence to get involved in care - reminds me some things that stay with and also makes me sad to remember what families were deprived of the pandemic )
He says we should follow up experiences with those whose relative died
I agree
(We do this and nursing staff lead it but there isn’t ‘consultant time’ allocated. I wonder if we can make more use of the potential for feedback)
❓Audience Q now leads to an answer to effect that a pt admitted to ITU just to die, shouldn’t be admitted
(I don’t agree - there are circumstances where it is the right thing for that patient in that hospital)
Actually - 2nd audience member has now stood up and said just that
We’re now on to Van Dijk and whole person palliative care…
Does it work?
Well the research is often observational, qualitative and single author
(So we’re skeptical, is the vibe I’m getting)
There is an RCT (not ITU) that showed a moderate improvement in experience (substantial loss to follow up- outcome at 6 mths….) pubmed.ncbi.nlm.nih.gov/28133973/
This systematic review again
(And so I definitely want to read this now so hopefully will remember it is here 🐘)
I am frustratingly unable to access my @ESICM account at the moment so can’t get into @yourICM. So it will have to keep fro a rainy day.
🧠 Heading here this morning for joint @ERC_resus session ‘How do I predict neurological outcome after cardiac arrest” at #LIVES2022
This is a core part of my day to day and frequent conversation I have with the junior team so interested to listen …
So far the audience have been asked four times to move closer to the front. Nobody moves.
The first q is ‘how do you do it’.
Sandroni says Neuron specific enolase (NSE) for 3 days, clinical exam from day 3, EEG starting early…used later, CT is repeated in patients with prolonged unconsciousness and MRI in those that aren’t waking up..
🫁 🧬 ARDS in Sepsis - Are biomarkers helpful? #LIVES2022
(The answer for me is - minimally…I rarely have access to them at the beside 🛌 but I presume the answer from JM Constantin has meat to it, so I’m here to listen)
We start here by asking is ARDS due to sepsis the same as that due to peritonitis or pneumonia?
And he has now changed the title to Are biomarkers helpful in ARDS?
One of the useful things about a conference in Europe is the opportunity to understand a breath of socio-cultural perspectives (it’s almost like we’re better together 💁🏻♀️🇪🇺)
Anyway, looking forward to this - let’s go #LIVES2022
This is a joint session from ethics and metabolism & nutrition section. They start with Arabi who highlights the variability - he’s trained in US, works in Saudia Arabia and has relationship with Australia
He highlights that there is more agreement for withholding than withdrawing nutrition and that attitude are surprisingly consistent across this large part of the world
He then says that artificial nutrition in Saudia Arabia is more likely to be considered a basic part of care